Diagnostics to help reduce the burden of disease
Nonagen Bioscience is working to translate research discoveries into best-in-class diagnostics that change the way diseases are managed.
Our sights are set on providing doctors with advanced diagnostic tools for disease detection, therapy choice, and disease monitoring.
The promise of Oncuria®
Oncuria is a first-of-its-kind multiplex protein immunoassay being developed to:
DETECT—Aid in the diagnosis of bladder cancer
MONITOR—Monitor people with early-stage bladder cancer for recurrence
PREDICT—Help identify people who are more likely to experience rapid failure with bacillus Calmette-Guérin (BCG) therapy, a first-line treatment for bladder cancer